Kintara Therapeutics Inc (KTRA): $KTRA Whelp folks... Been "wrenching" on...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Kintara Therapeutics Inc (KTRA)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	339
Posts	7425
Boards Moderated	0
Alias Born	07/12/2009

Re: None

Thursday, 02/01/2024 2:50:13 PM

Thursday, February 01, 2024 2:50:13 PM

$KTRA Whelp folks... Been "wrenching" on the DD for $KTRA Yes there are MANY shares available to borrow and short and THAT in and OF itself is rather criminal...but the ACTUAL # of shares short currently are negligible. The "Days to cover" is between .05 - 1 Day...That nothing...so...not expecting a "squeeze"...

It is now my firm, experienced belief that $KTRA is being manipulated and being "held down" on purpose for reasons of "accumulation" at these "sub .25" levels.

Everyone knows the "nano-float" on this ticker...I believe the sudden climbs yesterday were an "info leak" which caught MM's off guard... The coming news which WILL Rocket $KTRA is either word on their remaining treatment ready for Phase III OR it's word on a "merger / buyout".

Robert E. Hoffman is CEO of $KTRA and on the board of newly NAZ public $FBLG . The "DOTS" are connecting. I believe $KTRA will soon be found!

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent KTRA News

Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 06/13/2024 08:10:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:05:11 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 06/03/2024 12:50:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 12:45:11 PM
TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) • PR Newswire (US) • 06/03/2024 12:35:00 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/17/2024 08:10:11 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/17/2024 08:05:37 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 05/14/2024 08:55:04 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:50:14 PM
Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results • PR Newswire (US) • 05/14/2024 08:45:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:40:36 PM
Form S-4 - Registration of securities, business combinations • Edgar (US Regulatory) • 05/13/2024 08:06:50 PM
Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm • PR Newswire (US) • 04/05/2024 05:09:00 PM
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement • PR Newswire (US) • 04/03/2024 11:00:00 AM
Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab • PR Newswire (US) • 03/27/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 11:59:49 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:00:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 12:00:10 PM
Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update • PR Newswire (US) • 02/14/2024 09:07:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:05:27 PM
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer • PR Newswire (US) • 02/12/2024 02:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:10:10 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/18/2023 09:05:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:15:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 02:10:19 PM

More KTRA News

InvestorsHub NewsWire

FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM

Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM

Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow